Viewing Study NCT00632359


Ignite Creation Date: 2025-12-24 @ 2:58 PM
Ignite Modification Date: 2026-02-01 @ 2:38 PM
Study NCT ID: NCT00632359
Status: COMPLETED
Last Update Posted: 2020-02-10
First Post: 2008-03-03
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Lenalidomide in Chronic Lymphocytic Leukemia (CLL) Patients With Residual Disease
Sponsor: M.D. Anderson Cancer Center
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Chronic Lymphocytic Leukemia View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Chronic Lymphocytic Leukemia View
None CLL View
None Lenalidomide View
None Revlimid View